102 related articles for article (PubMed ID: 3931004)
21. The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Burns RS; LeWitt PA; Ebert MH; Pakkenberg H; Kopin IJ
N Engl J Med; 1985 May; 312(22):1418-21. PubMed ID: 2581135
[TBL] [Abstract][Full Text] [Related]
22. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Sirinathsinghji DJ; Whittington PE; Audsley AR
Brain Res; 1986 Dec; 399(2):339-45. PubMed ID: 2435361
[TBL] [Abstract][Full Text] [Related]
23. MPTP effects on dopamine neurons.
Kopin IJ
Ann N Y Acad Sci; 1988; 537():451-61. PubMed ID: 3059935
[No Abstract] [Full Text] [Related]
24. Transplantation of embryonic marmoset dopaminergic neurons to the corpus striatum of marmosets rendered parkinsonian by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Fine A; Hunt SP; Oertel WH; Nomoto M; Chong PN; Bond A; Waters C; Temlett JA; Annett L; Dunnett S
Prog Brain Res; 1988; 78():479-89. PubMed ID: 3150110
[No Abstract] [Full Text] [Related]
25. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion.
Gal S; Zheng H; Fridkin M; Youdim MB
J Neurochem; 2005 Oct; 95(1):79-88. PubMed ID: 16181414
[TBL] [Abstract][Full Text] [Related]
26. [Study of extracellular concentration of dopamine and its metabolites in mice striatum by a microdialysis technique at intraperitoneal administration of MPTP].
Averkin RG; Korshunov VA; Shchegolevskiĭ NV; Mats VN; Markevich VA; Grigor'ian GA; Bazian AS
Zh Vyssh Nerv Deiat Im I P Pavlova; 2010; 60(1):109-19. PubMed ID: 20352690
[TBL] [Abstract][Full Text] [Related]
27. Localization of neurotensin receptors in the forebrain of the common marmoset and the effects of treatment with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Waters CM; Hunt SP; Jenner P; Marsden CD
Brain Res; 1987 Jun; 412(2):244-53. PubMed ID: 3038264
[TBL] [Abstract][Full Text] [Related]
28. Effects of allopurinol on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurochemical changes in the striatum and in the brainstem of the rat.
Miele M; Esposito G; Migheli R; Sircana S; Zangani D; Fresu GL; Desole MS
Neurosci Lett; 1995 Jan; 183(3):155-9. PubMed ID: 7739783
[TBL] [Abstract][Full Text] [Related]
29. Lack of change in basal ganglia neuropeptide content following subacute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of the common marmoset.
Jenner P; Taquet H; Mauborgne A; Benoliel JT; Cesselin F; Rose S; Javoy-Agid F; Agid Y; Marsden CD
J Neurochem; 1986 Nov; 47(5):1548-51. PubMed ID: 2428937
[TBL] [Abstract][Full Text] [Related]
30. Pathology of MPTP in the marmoset.
Gibb WR; Lees AJ; Wells FR; Barnard RO; Jenner P; Marsden CD
Adv Neurol; 1987; 45():187-90. PubMed ID: 3103386
[No Abstract] [Full Text] [Related]
31. MPTP-induced parkinsonism in the common marmoset: behavioral and biochemical effects.
Jenner P; Rose S; Nomoto M; Marsden CD
Adv Neurol; 1987; 45():183-6. PubMed ID: 2881443
[No Abstract] [Full Text] [Related]
32. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) accelerates the accumulation of lipofuscin in mouse adrenal gland.
Hadjiconstantinou M; Tjioe S; Alho H; Miller C; Neff NH
Neurosci Lett; 1987 Dec; 83(1-2):1-6. PubMed ID: 3502018
[TBL] [Abstract][Full Text] [Related]
33. [A mouse model of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced parkinsonism: effect of norepinephrine terminal destruction].
Nishi K; Kondo T; Narabayashi H
No To Shinkei; 1987 Jul; 39(7):663-72. PubMed ID: 3314916
[TBL] [Abstract][Full Text] [Related]
34. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 5,7-dihydroxytryptamine on the locomotor activity and striatal amines in C57BL/6 mice.
Chia LG; Ni DR; Cheng LJ; Kuo JS; Cheng FC; Dryhurst G
Neurosci Lett; 1996 Oct; 218(1):67-71. PubMed ID: 8939482
[TBL] [Abstract][Full Text] [Related]
35. Biogenic monoamines in the cyclostome and lower vertebrate brain.
Baumgarten HG
Prog Histochem Cytochem; 1972; 4(1):1-90. PubMed ID: 4354409
[No Abstract] [Full Text] [Related]
36. Effects of bifemelane on parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset.
Nomoto M; Irifune M; Fukuzaki K; Fukuda T
Neurosci Lett; 1994 Aug; 178(1):95-8. PubMed ID: 7816348
[TBL] [Abstract][Full Text] [Related]
37. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the dog: effect of pargyline pretreatment.
Johannessen JN; Chiueh CC; Bacon JP; Garrick NA; Burns RS; Weise VK; Kopin IJ; Parisi JE; Markey SP
J Neurochem; 1989 Aug; 53(2):582-9. PubMed ID: 2568405
[TBL] [Abstract][Full Text] [Related]
38. Effect of cysteine on the persistent depletion of brain monoamines by amphetamine, p-chloroamphetamine and MPTP.
Steranka LR; Rhind AW
Eur J Pharmacol; 1987 Jan; 133(2):191-7. PubMed ID: 3493165
[TBL] [Abstract][Full Text] [Related]
39. Increase of plasma adrenocorticotrophin and cortisol in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated dogs.
Mizobuchi M; Hineno T; Kakimoto Y; Hiratani K
Brain Res; 1993 May; 612(1-2):319-21. PubMed ID: 8101134
[TBL] [Abstract][Full Text] [Related]
40. In vitro release of tritiated monoamines from rat CNS tissue by the neurotoxic compound 1-methyl-phenyl-tetrahydropyridine.
Schmidt CJ; Matsuda LA; Gibb JW
Eur J Pharmacol; 1984 Aug; 103(3-4):255-60. PubMed ID: 6333347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
